Basic & Clinical Medicine ›› 2024, Vol. 44 ›› Issue (3): 398-402.doi: 10.16352/j.issn.1001-6325.2024.03.0398
• Mini Reviews • Previous Articles Next Articles
WANG Zihao, XIA Xiaochao, LI Shun*
Received:
2023-05-16
Revised:
2023-11-29
Online:
2024-03-05
Published:
2024-02-22
Contact:
*:morelee@163.com
CLC Number:
WANG Zihao, XIA Xiaochao, LI Shun. Research progress on the role of transmembrane proteins in malignant tumors[J]. Basic & Clinical Medicine, 2024, 44(3): 398-402.
[1] | Bae Y, Lee SK, Chae YC, et al. Accessibility-dependent topology studies of membrane proteins using a SpyTag/SpyCatcher protein-ligation system[J]. Int J Biol Macromol, 2021, 175: 171-178. |
[2] | Zhang N, Pan H, Liang X, et al. The roles of transmembrane family proteins in the regulation of store-operated Ca2+ entry[J]. Cell Mol Life Sci, 2022, 79: 118.doi:10.1007/s00018-021-04034-y. |
[3] | Li C, Ou R, Chen Y, et al. Mutation analysis of TMEM family members for early-onset Parkinson′s disease in Chinese population[J]. Neurobiol Aging, 2021, 101: 299.e1-299.e6.doi:10.1016/j.neurobiolaging.2020.11.005. |
[4] | Ji W, Shi D, Shi S, et al. TMEM16A protein: calcium-binding site and its activation mechanism[J]. PPL, 2021, 28: 1338-1348. |
[5] | Ma K, Liu S, Liang H, et al. Ca2+-activated Cl-channel TMEM16A inhibition by cholesterol promotes angiogenesis in endothelial cells[J]. J Adv Res, 2021, 29: 23-32. |
[6] | Luo S, Wang H, Bai L, et al. Activation of TMEM16A Ca2+-activated Cl-channels by ROCK1/moesin promotes breast cancer metastasis[J]. J Adv Res, 2021, 33: 253-264. |
[7] | Yang J, Chen J, Del Carmen Vitery M, et al. PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel[J]. Science, 2019, 364: 395-399. |
[8] | Zha X, Xiong Z, Simon R, et al. pH and proton-sensitive receptors in brain ischemia[J]. J Cereb Blood Flow Metab, 2022,42:1349-1363. |
[9] | Mihaljević L, Ruan Z, Osei-Owusu J, et al. Inhibition of the proton-activated chloride channel PAC by PIP2[J]. eLife, 2023, 12: e83935. doi: 10.7554/eLife.83935. |
[10] | Peng F, Li H, Li J, et al.Downregulation of the proton-activated Cl- channel TMEM206 inhibits malignant properties of human osteosarcoma cells[J]. Oxid Med Cell Longev, 2021, 2021: 1-16. |
[11] | Li M, Zhu H, Hu X, et al. TMEM98, a novel secretory protein, promotes endothelial cell adhesion as well as vascular smooth muscle cell proliferation and migration[J]. Can J Physiol Pharmacol, 2021, 99: 536-548. |
[12] | Li J, Chen W, Luo L, et al. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma[J]. Aging, 2021, 13: 769-781. |
[13] | Ao X, Li X, Chen Y, et al. TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein[J]. Cell Biol Int, 2020, 44: 1820-1830. |
[14] | Wu SG, Xu JY, Lei J, et al. Tumor-suppressor gene transmembrane protein 98 promotes proliferation and inhibits apoptosis in ovarian cancer[J]. Front Biosci(Landmark Ed), 2022, 27: 210. doi: 10.31083/j.fbl2707210. |
[15] | He Q, Dong Y, Zhu Y, et al. TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis[J]. Oncol Rep, 2021, 45: 63. doi: 10.3892/or.2021.8014. |
[16] | Li H, Cheng C, You W, et al. TMEM100 modulates TGF-β signaling pathway to inhibit colorectal cancer progression[J]. Gastroent Res Pract, 2021, 2021: 1-10. |
[17] | Ye Z, Xia Y, Li L, et al. Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway[J]. Transl Oncol, 2023, 27: 101578. doi: 10.1016/j.tranon.2022.101578. |
[18] | Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Sig Transduct Target Ther, 2022, 7: 3. doi: 10.1038/s41392-021-00762-6. |
[19] | Xu J, Su Z, Ding Q, et al. Inhibition of proliferation by knockdown of transmembrane (TMEM) 168 in glioblas-toma cells via suppression of Wnt/β-Catenin pathway[J]. oncol res, 2019, 27: 819-826. |
[20] | Jiang XY, Wang L, Liu ZY, et al. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway[J]. J Recept Sig Transd, 2021, 41: 371-377. |
[21] | Zhao X, Li G, Chong T, et al. TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling[J]. J Biochem Molecular Tox, 2021, 35: e22835. doi: 10.1002/jbt.22835. |
[22] | Chen J, Wang D, Chen H, et al. TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway[J]. J Cancer Res Clin Oncol, 2023, 149: 653-667. |
[23] | Revathidevi S, Munirajan AK. Akt in cancer: mediator and more[J]. Semin Cancer Biol, 2019, 59: 80-91. |
[24] | Zhan B, Zhang Z, Piao C, et al. The sigma-2 receptor/TMEM97 agonist PB28 suppresses cell proliferation and invasion by regulating the PI3K-AKT-mTOR signalling pathway in renal cancer[J]. J Cellular Molecular Medi, 2021, 25: 11244-11256. |
[25] | Zhang X, He Y, Jiang Y, et al. TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway[J]. Oncol Rep, 2021, 46: 176. doi: 10.3892/or.2021.8127. |
[26] | Tchounwou PB, Dasari S, Noubissi FK, et al. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy[J]. JEP, 2021, 13: 303-328. |
[27] | Shen D, Ma J, Okabe M, et al. Elevated expression of TMEM205, a hypothetical membrane protein, is associa-ted with cisplatin resistance[J]. J Cell Physiol, 2010, 225: 822-828. |
[1] | LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang. Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis [J]. Basic & Clinical Medicine, 2024, 44(4): 503-512. |
[2] | LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua. lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 447-453. |
[3] | XU Lu, ZHANG Dongyu, WANG Ruifeng. Therapeutic effect of pachymic acid on Helicobacter pylori-associated gastritis in rats by regulating the PI3K/AKT/NF-κB signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(4): 489-495. |
[4] | YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473. |
[5] | GUO Hongjiang, XU Yeting, ZHANG Diya, QIU Jiaxing, WANG Yucheng, JU Rui, GUO Lei. Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 440-446. |
[6] | YANG Liu, TIAN Hui, JI Yuanyuan, HAN Xiaofang. Research progress on the role of the TMEM family of transmembrane proteins in the human reproductive system [J]. Basic & Clinical Medicine, 2024, 44(4): 568-571. |
[7] | ZHANG Zhongwen, ZHAO Rui, ZHANG Haolong, YANG Yuting, BAI Jinxia, ZHANG Haoling WANG Wei. Research progress on P2X7 receptor in cancer pain [J]. Basic & Clinical Medicine, 2024, 44(3): 389-392. |
[8] | NAN Lu, GUO Menjie, GAO Yanan, JIA Hongyan. Research progress on the mechanism of annexin A family members in breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 393-397. |
[9] | HAN Huijing, WU Hong, GE Yin, QIAO Juan. Dexmedetomidine alleviates lung tissue injury of rat models with ventilator-associated lung injury [J]. Basic & Clinical Medicine, 2024, 44(3): 339-345. |
[10] | ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332. |
[11] | Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping. Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 303-307. |
[12] | AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338. |
[13] | GUO Xin, JI Mengdie, WANG Qi, LI Xueyuan, CHEN Yang. Identification of the effect of cisplatin on the transcriptome of human hepatocellular carcinoma cell lines [J]. Basic & Clinical Medicine, 2024, 44(3): 352-360. |
[14] | ZHAO Yongzhong, XUE Yi, LI Liqun, HOU Mengsen, YANG Xiaojun. Early imaging and circulating marker features of gallbladder carcinoma [J]. Basic & Clinical Medicine, 2024, 44(2): 265-269. |
[15] | LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai. Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2024, 44(2): 247-251. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
京ICP备07012236号
Website Copyright © Basic & Clinical Medicine